Categories
Pharmaceutical

Demand for Renovascular Hypertension Treatment Growth Spurred by Increasing Prevalence of Kidney Disorders, Opines Fact.MR

Renovascular hypertension can be defined as high blood pressure caused by renal artery diseases mainly due to the narrowing of the renal artery. Renal artery diseases, such as renal artery stenosis, result in reduced blood flow due to the narrowing of the artery that provides blood to the kidney. When the kidney receives low blood flow, it responds by releasing hormones that stimulate the body to retain sodium and water as the blood pressure goes up.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=1725

Renovascular Hypertension Treatment Market: Segmentation

The global renovascular hypertension treatment market can be segmented on the basis of drug type, distribution channel and geography.

Based on drug type, the global renovascular hypertension treatment market is segmented as:

  • Angiotensin Converting Enzyme (ACE) Inhibitor
  • Diuretic
  • Angiotensin II Receptor Blockers
  • Others

Based on distribution channel, the global renovascular hypertension treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

Get Customization on this Report for Specific Country- https://www.factmr.com/connectus/sample?flag=RC&rep_id=1725

Renovascular Hypertension Treatment Market: Key Players

Examples of some of the key players operating in the global renovascular hypertension treatment market are

  • Abbott Laboratories
  • Pfizer Inc.
  • Novartis AG
  • Merck & Company, Inc.
  • AstraZeneca plc.
  • Johnson and Johnson
  • Eli Lilly and Company
  • Sanofi SA
  • Bayer AG
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • others

Companies are conducting clinical trials for the development of new renovascular hypertension treatment drugs, which is expected to boost the growth opportunities of the renovascular hypertension treatment market.

Renovascular Hypertension Treatment Market: Regional Outlook

Geographically, the global renovascular hypertension treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global renovascular hypertension treatment market owing to highly supportive government initiatives. Europe is expected to have the second-largest share in the global renovascular hypertension treatment market throughout the forecast period owing to the growing awareness related to major health issues. The renovascular hypertension treatment market in the Asia Pacific excluding Japan region is expected to grow at a significant CAGR due to an increase in healthcare expenditure and growth in the number of healthcare facilities.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com